Table 4.
Postprocedural outcome and in-hospital complications.
| Occluder system | Total | P-value | ||
|---|---|---|---|---|
| SOPT | DODT | |||
| N | 60 | 89 | 149 | |
| In-hospital death | 0 (0%) | 0 (0%) | 0 (0%) | ns |
| Bleeding complication | 5 (8.3%) | 5 (5.6%) | 10 (6.7%) | 0.75 |
| Device-related thrombus | 0 (0%) | 0 (0%) | 0 (0%) | ns |
| Access-side complication | 5 (8.3%) | 6 (6.7%) | 11 (7.4%) | 0.96 |
| TIA or stroke | 0 (0%) | 0 (0%) | 0 (0%) | ns |
| Pericardial tamponade | 0 (0%) | 2 (2.2%) | 2 (1.3%) | 0.16 |
| Postprocedural anticoagulation | ||||
| OAC (Vit-K AG) | 2 (3.4%) | 2 (2.2%) | 4 (2.7%) | 1 |
| NOAC | 17 (28.8%) | 32 (36.0%) | 49 (33.1%) | 0.47 |
| Dual antiplatelet (AS ± P2Y12AG) | 40 (67.8%) | 50 (56.2%) | 90 (60.8%) | 0.21 |
| Heparin | 1 (1.7%) | 5 (9.0%) | 6 (6.1%) | 0.14 |
Values are displayed as frequencies (%) or mean (standard deviation).